Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 96Rectal Neoplasms 42Colonic Neoplasms 38Stomach Neoplasms 31Pancreatic Neoplasms 31Neoplasm Metastasis 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Neoplasms 21Esophageal Neoplasms 19Burkitt Lymphoma 15Adenocarcinoma Of Esophagus 14Lymphoma 13Leukemia 8Adenocarcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Osteosarcoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Biphenotypic, Acute 4Gastrointestinal Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Hepatocellular 4Liver Neoplasms 3Intestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Bile Duct Neoplasms 3Somatostatinoma 2

Interventions

Oxaliplatin 1Levoleucovorin 1Leucovorin 1Folfox protocol 1Fluorouracil 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Malignant Solid Tumour × Leucovorin × Clear all
NCT01611857 2016-11-23

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

SCRI Development Innovations, LLC

Phase 1/2 Completed
49 enrolled 12 charts
GastrointestinalOther solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡